CMN 571 - Final Exam Question and answers
rated A+
USPSTF | - | B/P | screenings | start | at | what | age? | - | 18 | for | everyone
USPSTF | - | Daily | ASA | regimens | are | recommended | for | what | age
| groups? | Men |and | Women | - | Men | - | 45-79 | (to | prevent | MI)
Women | - | 55-79 | (to | prevent | ischemic | CVA)
USPSTF | - | Who | should | be | screened | for | AAA? | And | how? | - | Men | 65-
75 | by | U/S
USPSTF | - | Diagnostic | workup | of | HTN | includes | which | labs? | - | U/A, | BG,
| Hct, |Lipid | panel, | K, | Cr, | Ca.
Optional: | Urinary | albumin/cr | ratio.
USPSTF | - | Major | CVD | Risk | factor | includes | GFR | < | ? | - | GFR | < | 60
USPSTF | - | Identifiable | causes | of | HTN? | - | Sleep | apnea | • | Drug | induced/related
• Chronic | kidney | disease | • | Primary | aldosteronism | • | Renovascular
| disease | • |Cushing's | syndrome | or | steroid | therapy | • | Pheochromocytoma | •
| Coarctation | of |aorta | • | Thyroid/parathyroid | disease
JNC-7 | recommends | what | 5 | lifestyle | modifications | to | manage | HTN? | - | -
| Wt. |reduction
- DASH | diet
- Na | reduction
- Physical | activity
- Moderation | of | alcohol | consumption
JNC-7 | daily | sodium | consumption | recommendation? | - | 2.4
| grams |JNC-7 | Normal | BP | is.. | - | <120 | SBP/<80 | DBP
JNC-7 | PreHTN | is... | - | 120-139
| SBP |80-89 | DBP
JNC-7 | Stage | 1 | HTN | is... | - | 140-159
| SBP |90-99 | DBP
JNC-7 | Stage | 2 | HTN | is... | - | ≥160 | SBP
≥ | 100 | DBP
DASH | diet | recommended | daily | Cholesterol | intake?
,a. 100 | mg
b. 125 | mg
c. 150 | mg
d. 175 | mg | - | c. | 150 | mg
DASH | diet | recommended | daily | Sodium | intake | for | a | middle-aged | black
| man |with | HTN?
a. 1000 | mg
b. 1500 | mg
c. 2000 | mg
d. 2300 | mg | - | b. | 1500 | mg
DASH | diet | recommends | daily | Sodium | intake | for | the | young | adult | with
| B/P |110/50?
a. 1000 | mg
b. 1500 | mg
c. 2000 | mg
d. 2300 | mg | - | d. | 2300 | mg
DASH | diet | recommended | daily | Potassium | intake?
a. 1700 | mg
b. 2700 | mg
c. 3700 | mg
d. 4700 | mg | - | d. | 4700 | mg
DASH | diet | recommended | daily | Calcium | intake?
a. 1000 | mg
b. 1250 | mg
c. 1500 | mg
d. 1750 | mg | - | b. | 1250 | mg
DASH | diet | recommended | daily | Magnesium | intake?
a. 500 | mg
b. 750 | mg
c. 1000 | mg
d. 1250 | mg | - | a. | 500 | mg
DASH | diet | recommended | daily | Fiber | intake?
a. 15 | gm
b. 30 | gm
c. 45 | gm
d. 60 | gm | - | b. | 30 | gm
Cancer | screening | in | women | focuses | on...
a. Primary | prevention
b. Secondary | prevention
,c. Tertiary | prevention | - | b. | secondary | prevention
The | Framingham | risk | calculator | is | used | to | estimate | a | woman's | 10-
year | risk |of | CHD | based | on | what | 4 | things? | - | - | Age
- B/P
- Cholesterol
- Smoking
NCEP | recommends | all | women | over | what | age | be | screened | for | hyperlipidemia?
a. 20
b. 35
c. 45
d. 55 | - | a. | 20
Which | of | the | following | is | more | predictive | of | CHD | risk | in | women?
a. Elevated | LDL
b. Low | HDL
c. Elevated | TC
d. Elevated | Triglycerides | - | b. | Low | HDL
All |of | the | following | increase | a | woman's | risk | for | breast | CA, | EXCEPT..
a. Age
b. Family | History
c. Alcohol | Intake
d. Dietary | Intake | - | d. | Dietary | Intake
Which | of | the | following | has | NOT | been | found | to | reduce | breast | cancer
|mortality?
a. Screening | mammography
b. Clinical | breast | exam
c. Self-breast | exam
d. All | of | the | above | reduce | breast | CA | mortality. | - | c. | Self-breast | exam
- USPSTF | does | NOT | recommend | teaching | women | to | do | BSEs.
Define | primary | prevention | - | aims | to | remove | or | reduce | disease | risk
| factors |ie. | immunizations, | giving | up | or | not | start | smoking
Define | secondary | prevention | - | promotes | early | detection | of | disease | or
|precursor | states
ie. | cervical | Pap | screening
Define | teritiary | prevention | - | limit | the | impact | of | established | disease
ie. | partial | mastectomy | and | radiation | therapy | to | remove | and | control
| localized |breast | Ca
What | are | the | 3 | top | leading | causes | of | death | in | the | U.S.? | - | 1. | Heart | dz
, 2. malignant | neoplasms
3. chronic | lower | respiratory | dz
In | the | ASYMPTOMATIC | HIV-infected | patient | what | modifications | would
| you |make | to | their | scheduled | vaccinations? | - | The | clinician | would | not
| give | the |ACTIVATED | form | of | poliomyelitis | vaccine. | Only | the | inactivated
| version | is |indicated. | All | other | vaccines | are | okay.
In | the | SYMPTOMATIC | HIV-infectied | patient | what | modifications | would
| you |make | to | their | scheduled | vaccinations? | - | Avoid | all | live | virus
| vaccines.
Your | patient | comes | in | after | an | allogenic | bone | marrow | transplant. | Which
|vaccines | are | indicated? | - | All | vaccines | are | indicated, | the | pt | has | host
| pre- |existing | immunities. | Oral | live | polio | vaccine | should | be | avoided.
Who | is | the | zoster | vaccination | contraindicated | in?
a. people | 60 | and | older
b. immunocompromised
c. women | of | child-bearing | age
d. all | of | the | above | - | B. | immunocompromised
Which | of | the | following | patients | should | be | screened | for | lipid | disorder?
a. 32 | y.o. | male | with | history | of | ETOH | use
b. 20 | y.o. | male | who | smokes
c. 48 | y.o. | female | with | a | normal | HgbA1C
d. none | of | the | above | - | B. | Beginning | at | age | 20, | men | with | risk
| factors | should | be | screened.
Women | without | risk | factors | don't | have | to | be | screened | according | to | table | 1-
3.
Smoking | increases | your | risk | for | which | of | the | following | diseases
a. osteporosis
b. breast | Ca
c. Alzheimer's | disease
d. all | of | the | above | - | D
A | patient | would | like | to | Bupropion | to | aid | with | smoking | cessation.
| Which | of |the | following | is | a | contraindication?
a. history | of | seizure | disorder
b. depression
c. COPD
d. patients | already | using | a | nicotine | patch | - | A
How | much | calcium | supplementation | is | necessary | to | decrease | fracture
| risk? | - |1200mg | per | day | or | more | with | or | without | Vit | D
rated A+
USPSTF | - | B/P | screenings | start | at | what | age? | - | 18 | for | everyone
USPSTF | - | Daily | ASA | regimens | are | recommended | for | what | age
| groups? | Men |and | Women | - | Men | - | 45-79 | (to | prevent | MI)
Women | - | 55-79 | (to | prevent | ischemic | CVA)
USPSTF | - | Who | should | be | screened | for | AAA? | And | how? | - | Men | 65-
75 | by | U/S
USPSTF | - | Diagnostic | workup | of | HTN | includes | which | labs? | - | U/A, | BG,
| Hct, |Lipid | panel, | K, | Cr, | Ca.
Optional: | Urinary | albumin/cr | ratio.
USPSTF | - | Major | CVD | Risk | factor | includes | GFR | < | ? | - | GFR | < | 60
USPSTF | - | Identifiable | causes | of | HTN? | - | Sleep | apnea | • | Drug | induced/related
• Chronic | kidney | disease | • | Primary | aldosteronism | • | Renovascular
| disease | • |Cushing's | syndrome | or | steroid | therapy | • | Pheochromocytoma | •
| Coarctation | of |aorta | • | Thyroid/parathyroid | disease
JNC-7 | recommends | what | 5 | lifestyle | modifications | to | manage | HTN? | - | -
| Wt. |reduction
- DASH | diet
- Na | reduction
- Physical | activity
- Moderation | of | alcohol | consumption
JNC-7 | daily | sodium | consumption | recommendation? | - | 2.4
| grams |JNC-7 | Normal | BP | is.. | - | <120 | SBP/<80 | DBP
JNC-7 | PreHTN | is... | - | 120-139
| SBP |80-89 | DBP
JNC-7 | Stage | 1 | HTN | is... | - | 140-159
| SBP |90-99 | DBP
JNC-7 | Stage | 2 | HTN | is... | - | ≥160 | SBP
≥ | 100 | DBP
DASH | diet | recommended | daily | Cholesterol | intake?
,a. 100 | mg
b. 125 | mg
c. 150 | mg
d. 175 | mg | - | c. | 150 | mg
DASH | diet | recommended | daily | Sodium | intake | for | a | middle-aged | black
| man |with | HTN?
a. 1000 | mg
b. 1500 | mg
c. 2000 | mg
d. 2300 | mg | - | b. | 1500 | mg
DASH | diet | recommends | daily | Sodium | intake | for | the | young | adult | with
| B/P |110/50?
a. 1000 | mg
b. 1500 | mg
c. 2000 | mg
d. 2300 | mg | - | d. | 2300 | mg
DASH | diet | recommended | daily | Potassium | intake?
a. 1700 | mg
b. 2700 | mg
c. 3700 | mg
d. 4700 | mg | - | d. | 4700 | mg
DASH | diet | recommended | daily | Calcium | intake?
a. 1000 | mg
b. 1250 | mg
c. 1500 | mg
d. 1750 | mg | - | b. | 1250 | mg
DASH | diet | recommended | daily | Magnesium | intake?
a. 500 | mg
b. 750 | mg
c. 1000 | mg
d. 1250 | mg | - | a. | 500 | mg
DASH | diet | recommended | daily | Fiber | intake?
a. 15 | gm
b. 30 | gm
c. 45 | gm
d. 60 | gm | - | b. | 30 | gm
Cancer | screening | in | women | focuses | on...
a. Primary | prevention
b. Secondary | prevention
,c. Tertiary | prevention | - | b. | secondary | prevention
The | Framingham | risk | calculator | is | used | to | estimate | a | woman's | 10-
year | risk |of | CHD | based | on | what | 4 | things? | - | - | Age
- B/P
- Cholesterol
- Smoking
NCEP | recommends | all | women | over | what | age | be | screened | for | hyperlipidemia?
a. 20
b. 35
c. 45
d. 55 | - | a. | 20
Which | of | the | following | is | more | predictive | of | CHD | risk | in | women?
a. Elevated | LDL
b. Low | HDL
c. Elevated | TC
d. Elevated | Triglycerides | - | b. | Low | HDL
All |of | the | following | increase | a | woman's | risk | for | breast | CA, | EXCEPT..
a. Age
b. Family | History
c. Alcohol | Intake
d. Dietary | Intake | - | d. | Dietary | Intake
Which | of | the | following | has | NOT | been | found | to | reduce | breast | cancer
|mortality?
a. Screening | mammography
b. Clinical | breast | exam
c. Self-breast | exam
d. All | of | the | above | reduce | breast | CA | mortality. | - | c. | Self-breast | exam
- USPSTF | does | NOT | recommend | teaching | women | to | do | BSEs.
Define | primary | prevention | - | aims | to | remove | or | reduce | disease | risk
| factors |ie. | immunizations, | giving | up | or | not | start | smoking
Define | secondary | prevention | - | promotes | early | detection | of | disease | or
|precursor | states
ie. | cervical | Pap | screening
Define | teritiary | prevention | - | limit | the | impact | of | established | disease
ie. | partial | mastectomy | and | radiation | therapy | to | remove | and | control
| localized |breast | Ca
What | are | the | 3 | top | leading | causes | of | death | in | the | U.S.? | - | 1. | Heart | dz
, 2. malignant | neoplasms
3. chronic | lower | respiratory | dz
In | the | ASYMPTOMATIC | HIV-infected | patient | what | modifications | would
| you |make | to | their | scheduled | vaccinations? | - | The | clinician | would | not
| give | the |ACTIVATED | form | of | poliomyelitis | vaccine. | Only | the | inactivated
| version | is |indicated. | All | other | vaccines | are | okay.
In | the | SYMPTOMATIC | HIV-infectied | patient | what | modifications | would
| you |make | to | their | scheduled | vaccinations? | - | Avoid | all | live | virus
| vaccines.
Your | patient | comes | in | after | an | allogenic | bone | marrow | transplant. | Which
|vaccines | are | indicated? | - | All | vaccines | are | indicated, | the | pt | has | host
| pre- |existing | immunities. | Oral | live | polio | vaccine | should | be | avoided.
Who | is | the | zoster | vaccination | contraindicated | in?
a. people | 60 | and | older
b. immunocompromised
c. women | of | child-bearing | age
d. all | of | the | above | - | B. | immunocompromised
Which | of | the | following | patients | should | be | screened | for | lipid | disorder?
a. 32 | y.o. | male | with | history | of | ETOH | use
b. 20 | y.o. | male | who | smokes
c. 48 | y.o. | female | with | a | normal | HgbA1C
d. none | of | the | above | - | B. | Beginning | at | age | 20, | men | with | risk
| factors | should | be | screened.
Women | without | risk | factors | don't | have | to | be | screened | according | to | table | 1-
3.
Smoking | increases | your | risk | for | which | of | the | following | diseases
a. osteporosis
b. breast | Ca
c. Alzheimer's | disease
d. all | of | the | above | - | D
A | patient | would | like | to | Bupropion | to | aid | with | smoking | cessation.
| Which | of |the | following | is | a | contraindication?
a. history | of | seizure | disorder
b. depression
c. COPD
d. patients | already | using | a | nicotine | patch | - | A
How | much | calcium | supplementation | is | necessary | to | decrease | fracture
| risk? | - |1200mg | per | day | or | more | with | or | without | Vit | D
